Literature DB >> 18072935

A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis.

Kai-Fa Huang1, Yu-Ruei Wang, En-Cheng Chang, Tsung-Lin Chou, Andrew H-J Wang.   

Abstract

QCs (glutaminyl cyclases; glutaminyl-peptide cyclotransferases, EC 2.3.2.5) catalyse N-terminal pyroglutamate formation in numerous bioactive peptides and proteins. The enzymes were reported to be involved in several pathological conditions such as amyloidotic disease, osteoporosis, rheumatoid arthritis and melanoma. The crystal structure of human QC revealed an unusual H-bond (hydrogen-bond) network in the active site, formed by several highly conserved residues (Ser(160), Glu(201), Asp(248), Asp(305) and His(319)), within which Glu(201) and Asp(248) were found to bind to substrate. In the present study we combined steady-state enzyme kinetic and X-ray structural analyses of 11 single-mutation human QCs to investigate the roles of the H-bond network in catalysis. Our results showed that disrupting one or both of the central H-bonds, i.e., Glu(201)...Asp(305) and Asp(248)...Asp(305), reduced the steady-state catalysis dramatically. The roles of these two COOH...COOH bonds on catalysis could be partly replaced by COOH...water bonds, but not by COOH...CONH(2) bonds, reminiscent of the low-barrier Asp...Asp H-bond in the active site of pepsin-like aspartic peptidases. Mutations on Asp(305), a residue located at the centre of the H-bond network, raised the K(m) value of the enzyme by 4.4-19-fold, but decreased the k(cat) value by 79-2842-fold, indicating that Asp(305) primarily plays a catalytic role. In addition, results from mutational studies on Ser(160) and His(319) suggest that these two residues might help to stabilize the conformations of Asp(248) and Asp(305) respectively. These data allow us to propose an essential proton transfer between Glu(201), Asp(305) and Asp(248) during the catalysis by animal QCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18072935     DOI: 10.1042/BJ20071073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  4 in total

1.  Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.

Authors:  Kai-Fa Huang; Su-Sen Liaw; Wei-Lin Huang; Cho-Yun Chia; Yan-Chung Lo; Yi-Ling Chen; Andrew H-J Wang
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

2.  Structure of glutaminyl cyclase from Drosophila melanogaster in space group I4.

Authors:  Petr Kolenko; Birgit Koch; Jens Ulrich Rahfeld; Stephan Schilling; Hans Ulrich Demuth; Milton T Stubbs
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-03-28

3.  Repurposing FDA-Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.

Authors:  Chenshu Xu; Haoman Zou; Xi Yu; Yazhou Xie; Jiaxin Cai; Qi Shang; Na Ouyang; Yinan Wang; Pan Xu; Zhendan He; Haiqiang Wu
Journal:  ChemistryOpen       Date:  2020-12-30       Impact factor: 2.630

4.  Soluble variants of human recombinant glutaminyl cyclase.

Authors:  Cristiana Castaldo; Silvia Ciambellotti; Raquel de Pablo-Latorre; Daniela Lalli; Valentina Porcari; Paola Turano
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.